Scribe Therapeutics (SCTX) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 22 38 sessions, July 24, 2026 to September 16, 2026
- Largest daily move
- +27.9% close of August 18, 2026
Company Description
Scribe Therapeutics (NASDAQ: SCTX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $550.9M.
SCTX has gained 40.4% over the past month. The last closing price was $29.10.
This page collects what Stock Titan holds for SCTX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Scribe Therapeutics (SCTX) closed at $29.10 on September 16, 2026. Over the past month, the price has gained 40.4%.
SCTX Metrics & Rankings
Price returns through September 16, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Scribe Therapeutics has 4 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, conferences, IPO, private placement, offering. View all SCTX news →
SEC Filings
Scribe Therapeutics has filed 5 recent SEC filings, including 2 Form SCHEDULE 13D, 1 Form 4, 1 Form 10-Q, 1 Form 8-K. The most recent filing was submitted on September 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SCTX SEC filings →
Insider Radar
Insider buying activity at Scribe Therapeutics over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
Cell & Gene Meeting
Initial SAD data
Scribe Therapeutics has 2 upcoming scheduled events. The next event, "Cell & Gene Meeting", is scheduled for October 5, 2026 (in 19 days). Investors can track these dates to stay informed about potential catalysts that may affect the SCTX stock price.
Short Interest History
Short interest in Scribe Therapeutics (SCTX) currently stands at 778.2 thousand shares, up 173.3% from the previous reporting period, representing 5.0% of the float. Since July 2026, short interest has increased by 195.8%.
Days to Cover History
Days to cover for Scribe Therapeutics (SCTX) currently stands at 2.6 days, up 22.9% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 96.3% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.3 to 2.6 days.
SCTX Company Profile & Sector Positioning
Scribe Therapeutics (SCTX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.